14 Best Performing Dividend Stocks To Buy Now

2. AbbVie Inc. (NYSE:ABBV)

Year-to-Date Return as of March 7: 19.33%

AbbVie Inc. (NYSE:ABBV) is an American multinational biopharmaceutical company that mainly focuses on developing and commercializing innovative treatments across various healthcare fields. It holds one of the strongest dividend growth histories in the market, with 52 consecutive years of dividend growth under its belt. Its quarterly dividend comes in at $ 1.64 per share and has a dividend yield of 3.06%, as of March 7.

AbbVie Inc. (NYSE:ABBV) is a key player in the pharmaceutical industry, offering therapies in immunology, oncology, neurology, and eye care. Additionally, it has a strong presence in the aesthetics market, selling popular cosmetic products like Juvederm and Botox for skincare and anti-aging treatments. The stock has surged by over 19% since the start of 2025.

In the fourth quarter of 2024, AbbVie Inc. (NYSE:ABBV) reported revenue of $15.1 billion, reflecting a 5.6% year-over-year increase and exceeding analysts’ expectations of $14.87 billion. On a GAAP basis, the company posted a net loss of $0.02 per share, while adjusted diluted earnings per share (EPS) stood at $2.16, slightly above the forecasted $2.13. For the full year, combined sales of Skyrizi and Rinvoq reached $17.7 billion, surging 51% due to growing global demand and market expansion. Excluding Humira, the company’s total revenue saw an 18% annual increase, driven by strong growth in its neuroscience and oncology divisions.